With the use of our technology, biopharmaceutical companies in the area of Cell and Gene Therapy (CGT) and Personalized Medicine can minimize the risk of bio contamination, manipulation or product loss towards 0%.
For CGT many small batches of either buffer salts, primary cells or media, such as CAR-T, are supplied and delivered between biopharmaceutical companies, biotech companies, CMOs, CDMOs, hospitals and other suppliers.
In early stage clinical studies the volume of drug substance is very small, within a range of 1 ml to 500 ml. This process builds upon industry standards like single use bags of all sizes and manufacturers.
Scale-down to one single drop of drug substance! RoSS.KSET offers the protection for drug substances between 1 ml to 500 ml. For anything above, RoSS can protect one or multiple small single use bags in one shell.
Furthermore, we offer a framework of preventive and protective measures for this standard that reach a new and unrivaled quality level.
Our development features all strengths of single use bags. Potential weaknesses and risks, like material deficiencies or sensitive outer shells, are 100% compensated by our developments.
We call our process CGT.STREAM.